DrugPatentWatch Database Preview
Email this page to a colleagueSee Plans and Pricing
« Back to Dashboard
PBT-1033 is an investigational drug.
There have been 5 clinical trials for PBT-1033. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2008.
The most common disease conditions in clinical trials are Esophageal Neoplasms, Carcinoma, Non-Small-Cell Lung, and Acne Vulgaris. The leading clinical trial sponsors are Mayo Clinic, M.D. Anderson Cancer Center, and GlaxoSmithKline.
Recent Clinical Trials for PBT-1033
|Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer||National Cancer Institute (NCI)||Phase 3|
|Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer||NRG Oncology||Phase 3|
|Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy||xjpfW||N/A|